Bullish
Hoth Therapeutics Reports Positive HT VA Study Data Highlighting GDNF Driven Metabolic Reprogramming In Fatty Liver Disease
Hoth Therapeutics announced positive data from its HT-VA study, revealing that GDNF can reprogram liver fat metabolism at the genetic level in metabol...